Visit us at ESMO 2026

Booth 8071, hall 8

Learn how the Oncotype DX Breast Recurrence Score® test is the first and only multigene assay to go beyond prognosis and predict chemotherapy benefit1-6

Map of IFEMA Madrid showing the Oncotype DX booth 8071 in hall 8.

Where to find us

Booth 8071, hall 8

Date: 23-26 October 2026

Location: IFEMA Madrid

Av. Del Partenon, 5, Barajas, 28042, Madrid

Oncotype DX exhibition booth at ESMO 2026.

What to expect

  • Challenge and expand your knowledge through our interactive tool
  • Explore our brochures and sample reports, delivered directly to your inbox
  • Connect with our Medical and Commercial teams for deeper insights and discussion
Interactive Oncotype DX experience tool featuring educational content about the test and a Recurrence Score result challenge based on patient case examples.

Can you predict the Recurrence Score® result?

Explore our interactive tool to learn when and how the Oncotype DX® test can support treatment decision-making in HR+, HER2-, early-stage invasive breast cancer.

Review patient cases, predict the Recurrence Score result, and see how your estimate compares with the actual result through our interactive challenge.

Video celebrating more than 2 million patients tested with the Oncotype DX test.
Celebrate 2M+ patients tested with Oncotype DX and discover how we're helping to shape more confident treatment decisions.

Join our Industry Satellite Symposium

Redefining Colorectal Cancer Screening: From Evidence to Real-world Impact

26 October 2026 | 13:00 – 14:30 | Salamanca Auditorium, hall 10, IFEMA Madrid

Hear from internationally recognised experts as they discuss how smarter colorectal cancer screening pathways can translate evidence into measurable real-world impact and help shape the future of prevention.

Featuring Dr. Cesare Hassan, Dr. Clara Montagut, Dr. David Hyams and Dr. Paul Limburg